Insider
Danaher CorpDHR

Danaher raises full-year outlook after 8.5% revenue growth

Danaher raised third-quarter 2026 revenue 8.5% to $6.6 billion and raised its full-year profit outlook. Adjusted earnings per share rose 11.5% to $2.11.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
refill of liquid on tubes
Photo by Louis Reed on Unsplash
$6.6 billion
Quarterly revenue
$2.11
Adjusted EPS
8.5%
Revenue growth, y/y

Key points

  • Net earnings were $1.2 billion, or $1.71 per share, up 34.5% from a year earlier.
  • Guidance for 2026 adjusted earnings per share was raised to $8.57 to $8.62 from $8.45 to $8.60.
  • Danaher borrowed to pay part of the Masimo purchase price.

The Masimo deal added revenue

Net earnings were $1.2 billion, or $1.71 per share, up 34.5% from a year earlier. The result included one-time tax benefits of $263 million, mainly tied to settling tax audits.

Acquisitions, including Masimo, added 6.5% to sales growth. Excluding them and sales of respiratory infection tests, core revenue rose 5.5%.

Respiratory testing sales fell to about $350 million from about $500 million a year earlier.

Revenue by quarter, $B

6.5Q4 '24*21.8%5.7Q1 '2522.2%5.9Q2 '2512.8%6.1Q3 '2519.1%6.8Q4 '25*22%6Q1 '2622.6%6.3Q2 '2618%6.6Q3 '2619%
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.

New outlook and what management says

Guidance for 2026 adjusted earnings per share was raised to $8.57 to $8.62 from $8.45 to $8.60.

Earlier, on October 1, Julie Sawyer Montgomery took over as president and chief executive officer. She now said the quarter's revenue, earnings and cash flow were better than the company expected.

The price of the deal: more debt

Danaher borrowed to pay part of the Masimo purchase price. Interest expense rose to $135 million from $67 million a year earlier.

Demand from universities and government customers improved but remains weak. Prices fell 0.5%.

What to watch

In the fourth-quarter report, check whether adjusted earnings per share reaches the $8.57 to $8.62 range. The company also expects core revenue excluding respiratory tests to grow 4.0% to 5.0%.

Original sources

  1. 8-K EX-99.1 filing, October 21, 2026October 21, 2026SHA-256 of our archived copy 889be6e18aee…
  2. 10-Q filing, October 21, 2026October 21, 2026SHA-256 of our archived copy b9755d86410a…
  3. Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive OfficerOctober 1, 2026SHA-256 of our archived copy 90b4a21b8f99…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards